Cargando…
Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening
The European Lead Factory (ELF) consortium provides European academics and small and medium enterprises access to ~0.5 million unique compounds, a state-of-the-art ultra-high-throughput screening (u-HTS) platform, and industrial early drug discovery (DD) expertise with the aim of delivering innovati...
Autores principales: | Honarnejad, Saman, van Boeckel, Stan, van den Hurk, Helma, van Helden, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637381/ https://www.ncbi.nlm.nih.gov/pubmed/32734803 http://dx.doi.org/10.1177/2472555220942765 |
Ejemplares similares
-
Ultra-high-throughput Ca(2+) assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation
por: Fernández, Delia I., et al.
Publicado: (2021) -
Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective
por: Rainard, Julie M., et al.
Publicado: (2018) -
Advances in Ultrahigh
Throughput Hit Discovery with
Tandem Mass Spectrometry Encoded Libraries
por: Mata, J. Miguel, et al.
Publicado: (2023) -
CERN bringer of the apocalypse or hit factory?
Publicado: (2008) -
Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017)